Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

INTRODUCTION: Primary Sjögren’s syndrome (pSS) is an autoimmune disorder affecting exocrine glands; however, a subgroup of pSS patients experience systemic extra-glandular involvement leading to a worsening of disease prognosis. Current therapeutic options are mainly empiric and often translated by...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Carubbi, Francesco, Cipriani, Paola, Marrelli, Alessandra, Benedetto, Paola Di, Ruscitti, Piero, Berardicurti, Onorina, Pantano, Ilenia, Liakouli, Vasiliki, Alvaro, Saverio, Alunno, Alessia, Manzo, Antonio, Ciccia, Francesco, Gerli, Roberto, Triolo, Giovanni, Giacomelli, Roberto
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3979092/
https://ncbi.nlm.nih.gov/pubmed/24286296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4359
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars